Recurrent Tumor clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • REMASTer: REcurrent Brain Metastases After SRS Trial

    open to eligible people ages 18 years and up

    Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.

    Los Angeles, California and other locations

Our lead scientists for Recurrent Tumor research studies include .

Last updated: